News & Posts2021-07-22T03:51:57-04:00

Quality HTA at the EU ISPOR 2022

Quality HTA at the EU ISPOR 2022 - Quality HTA is pleased to announce the presentation of “Conditional Recommendations by the Canadian Agency for Drugs and Technologies in Health (CADTH)” at the ISPOR Conference [...]

By |October 22nd, 2022|Categories: News|Tags: |

Quality HTA at CAPT-ACTP 2022

CAPT-ACTP Conference 2022 - Quality HTA is pleased to announce the presentation of "Change and Trends in Conditional Recommendations; Analysis of CADTH Reports" at CAPT Conference 2022. This poster will be presented on Monday [...]

By |October 9th, 2022|Categories: News|

The CADTH Post-Market Drug Evaluation Program

The CADTH Post-Market Drug Program - CADTH has launched its Post-Market Evaluation Program to address the uncertainties around the appropriate use of drugs, their long-term safety, and effectiveness after use in the real world. [...]

By |September 3rd, 2022|Categories: News|

Where are we in RWE?

Where are we in RWE? - The best relevant RWD source needs to be decided depending on the research question. However, we still need some standard RWE frameworks, particularly when it comes to the [...]

By |May 7th, 2022|Categories: Posts|
Go to Top